COMMERZBANK AKTIENGESELLSCHAFT /FI - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 954 filers reported holding BAXTER INTL INC in Q1 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
COMMERZBANK AKTIENGESELLSCHAFT /FI ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2019$718,000
+223.4%
8,585
+238.1%
0.01%
+300.0%
Q3 2019$222,000
-27.0%
2,539
-32.2%
0.00%
-33.3%
Q1 2019$304,000
-1.0%
3,743
-19.7%
0.00%0.0%
Q4 2018$307,000
-51.6%
4,660
-43.3%
0.00%
-50.0%
Q3 2018$634,000
-33.3%
8,218
-36.2%
0.01%
-40.0%
Q2 2018$951,000
-51.1%
12,884
-56.9%
0.01%
-54.5%
Q1 2018$1,944,000
+25.0%
29,893
+24.2%
0.02%
+15.8%
Q4 2017$1,555,000
-3.0%
24,059
-5.8%
0.02%
-9.5%
Q3 2017$1,603,000
+46.9%
25,546
+41.7%
0.02%
+16.7%
Q2 2017$1,091,000
-25.3%
18,028
-36.0%
0.02%
-18.2%
Q1 2017$1,460,000
+29.8%
28,148
+10.9%
0.02%
+29.4%
Q4 2016$1,125,000
+66.7%
25,382
+79.0%
0.02%
+54.5%
Q3 2016$675,000
-38.6%
14,182
-41.7%
0.01%
+57.1%
Q2 2016$1,100,000
-14.1%
24,319
-22.0%
0.01%
-36.4%
Q1 2016$1,281,000
-45.7%
31,188
-49.6%
0.01%
-38.9%
Q4 2015$2,359,000
+35.7%
61,836
+16.8%
0.02%
+38.5%
Q3 2015$1,739,000
-69.1%
52,937
-34.2%
0.01%
-56.7%
Q2 2015$5,628,000
-2.5%
80,478
-4.5%
0.03%
-14.3%
Q1 2015$5,770,000
-15.2%
84,234
-9.3%
0.04%
-18.6%
Q4 2014$6,807,000
-52.8%
92,871
-53.8%
0.04%
-25.9%
Q3 2014$14,435,000
+25.6%
201,122
+26.5%
0.06%
-1.7%
Q2 2014$11,496,000
-3.0%
159,011
-1.3%
0.06%
+15.7%
Q1 2014$11,854,000
-17.0%
161,100
-23.0%
0.05%
-27.1%
Q4 2013$14,288,000
-34.9%
209,190
-37.3%
0.07%
-36.4%
Q3 2013$21,931,000
-57.4%
333,852
-55.0%
0.11%
-51.5%
Q2 2013$51,438,000742,5740.23%
Other shareholders
BAXTER INTL INC shareholders Q1 2014
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders